A yeast-expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates is a research paper published in Science Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 83 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: ORIP/OD P51OD011132
National Institutes of Health
Grant: 3U19AI057266-715
National Institutes of Health
Grant: HIPC COVID-19 S
National Institutes of Health
Grant: U19AI090023
National Institutes of Health
Grant: P30 A050509
National Institutes of Health
Grant: COVID-19 RBD
National Institute of Allergy and Infectious Diseases
Grant: P51-OD011132
National Institute of Allergy and Infectious Diseases
Grant: 22206
National Institute of Allergy and Infectious Diseases
Grant: 2020 COVID-19 CURE A
National Institute of Allergy and Infectious Diseases
Grant: 3U19AI057266-17S1
National Institute of Allergy and Infectious Diseases
Grant: 75N9301900065
National Institute of Allergy and Infectious Diseases
Grant: HHSN272201800004C
Baylor University
Grant: TLR-7/8 723
Scientific Advisory Board of MaxHealth 724 Biotechnology LLC
Grant: US 2019/0142935
NIH HHS
Grant: P51 OD011132
NIAID NIH HHS
Grant: U19 AI057266
FWCI
4.70
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals